Filing Details

Accession Number:
0001209191-18-009625
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-13 17:02:18
Reporting Period:
2018-02-13
Accepted Time:
2018-02-13 17:02:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590750 Miragen Therapeutics Inc. MGEN Services-Medical Laboratories (8071) 471187261
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1693134 Scott Adam Levy C/o Miragen Therapeutics, Inc.
6200 Lookout Road
Boulder CO 80301
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-13 9,090 $5.50 10,540 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents shares purchased through the Issuer's follow-on public offering.